Single-molecule characterization of cytoplasmic dynein
细胞质动力蛋白的单分子表征
基本信息
- 批准号:8269974
- 负责人:
- 金额:$ 29.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-03-01 至 2015-03-31
- 项目状态:已结题
- 来源:
- 关键词:Active Biological TransportAdenovirusesAffectAffinityAnimal ModelAxonal TransportBehaviorBindingBiochemicalBiochemistryBiologicalBiological AssayBrainCell physiologyCellsCognition DisordersCollaborationsComplementComplexDevelopmentDiseaseDisease ProgressionDynein ATPaseEndosomesGeneticHeadHealthHoloenzymesHumanImpairmentIn VitroKinesinKnowledgeLinkMediatingMicrotubulesMitochondriaModelingMolecular ConformationMolecular MotorsMotorMutagenesisMutationNerve DegenerationNervous System PhysiologyNeurobiologyNeuronsNuclearPathway interactionsPhosphorylationPhysiologicalPlayPositioning AttributePrincipal InvestigatorProcessProductionProtein KinaseProteinsPublic HealthRegulationRelative (related person)ReportingRisk FactorsRoleRotationSchizophreniaStructureTailTestingTherapeuticVirusWorkbasecofactordesigndynactingenetic regulatory proteinhuman diseaseimproved functioninglissencephalymigrationmutantneurodevelopmentpreventprogramsprotein complexreconstitutionresearch studysingle moleculetherapeutic target
项目摘要
DESCRIPTION (provided by applicant): Cytoplasmic dynein is a molecular motor crucially involved in many processes essential for correct neurological function. Its improper function causes failed neurodevelopment (e.g. Miller- Dieker Lissencephaly), neurodegeneration, and other cognitive diseases such as schizophrenia. The wide range of dynein roles is made possible by tuning its function with accessory proteins such as Lis1, NudE, and NudEL. However, while genetic studies, both via mutagenesis in model organisms, and via identification of causative/risk factors in human disease, have repeatedly established that these proteins are in the dynein pathway and are important for dynein function-that is, dynein-mediated transport is impaired when their function is lost-mechanistically it has been impossible to determine what they do, or why they are important. Lacking such knowledge makes understanding disease progression difficult, as well as making it impossible to rationally design therapeutic approaches to correct the impairments. Our work determines at a mechanistic level exactly how the different cofactors alter dynein function, and starts to determine the ways that these co-factors effects on dynein are themselves regulated. At a mechanistic level, we will better understand how dynein is turned off by NudE, and then re-activated by Lis1. At a global level, we will determine functionally what NudEL does to dynein function (if anything), and how the function of NudE, NudEL, and Lis1 are altered by phosphorylation. Since dynein is crucial for many aspects of neuronal function, this will importantly advance the general field of neurobiology, and possibly allow design of more targeted therapeutic approaches.
描述(由申请人提供):细胞质动力蛋白是一种分子马达,在正确的神经功能所必需的许多过程中起关键作用。它的功能不正常会导致神经发育失败(例如米勒-迪克尔无脑畸形)、神经变性和其他认知疾病,如精神分裂症。广泛的动力蛋白作用是通过调节其功能与辅助蛋白,如Lis 1,NudE和NudEL。然而,虽然遗传学研究,无论是通过在模式生物中的诱变,并通过识别人类疾病的致病/风险因素,已经反复建立了这些蛋白质是在动力蛋白途径和动力蛋白的功能是重要的,也就是说,动力蛋白介导的运输受损时,他们的功能是损失的机械已经不可能确定他们做什么,或者为什么他们是重要的。缺乏这些知识使得理解疾病进展变得困难,并且使得不可能合理地设计治疗方法来纠正损伤。我们的工作确定了在一个机械水平上,不同的辅助因子是如何改变动力蛋白功能的,并开始确定这些辅助因子对动力蛋白的影响是如何调节的。在机制层面上,我们将更好地理解动力蛋白是如何被NudE关闭,然后被Lis 1重新激活的。在全局水平上,我们将确定NudEL对动力蛋白功能的功能(如果有的话),以及NudE,NudEL和Lis 1的功能如何通过磷酸化改变。由于动力蛋白对神经元功能的许多方面至关重要,这将重要地推进神经生物学的一般领域,并可能允许设计更有针对性的治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEVEN P GROSS其他文献
STEVEN P GROSS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEVEN P GROSS', 18)}}的其他基金
Tuning Mitotic Kinesins Through Motor Domain Post Translational Modifications
通过运动域翻译后修饰调节有丝分裂驱动蛋白
- 批准号:
9893924 - 财政年份:2019
- 资助金额:
$ 29.53万 - 项目类别:
Tuning Mitotic Kinesins Through Motor Domain Post Translational Modifications
通过运动域翻译后修饰调节有丝分裂驱动蛋白
- 批准号:
10093091 - 财政年份:2019
- 资助金额:
$ 29.53万 - 项目类别:
Tuning Mitotic Kinesins Through Motor Domain Post Translational Modifications
通过运动域翻译后修饰调节有丝分裂驱动蛋白
- 批准号:
10348652 - 财政年份:2019
- 资助金额:
$ 29.53万 - 项目类别:
Single-molecule characterization of Cytoplasmic Dynein
细胞质动力蛋白的单分子表征
- 批准号:
6869225 - 财政年份:2005
- 资助金额:
$ 29.53万 - 项目类别:
Single-molecule characterization of cytoplasmic dynein
细胞质动力蛋白的单分子表征
- 批准号:
8119311 - 财政年份:2005
- 资助金额:
$ 29.53万 - 项目类别:
Single-molecule characterization of Cytoplasmic Dynein
细胞质动力蛋白的单分子表征
- 批准号:
7386620 - 财政年份:2005
- 资助金额:
$ 29.53万 - 项目类别:
Single-molecule characterization of cytoplasmic dynein
细胞质动力蛋白的单分子表征
- 批准号:
8636479 - 财政年份:2005
- 资助金额:
$ 29.53万 - 项目类别:
Single-molecule characterization of Cytoplasmic Dynein
细胞质动力蛋白的单分子表征
- 批准号:
7021396 - 财政年份:2005
- 资助金额:
$ 29.53万 - 项目类别:
Single-molecule characterization of cytoplasmic dynein
细胞质动力蛋白的单分子表征
- 批准号:
8449232 - 财政年份:2005
- 资助金额:
$ 29.53万 - 项目类别:
相似海外基金
cGAS-STING Pathway Targeting Replicative Adenoviruses with CD46 Tropism and AFP Promoter Conditional Replication Restriction for the Treatment of Hepatocellular Carcinoma
cGAS-STING 通路靶向具有 CD46 趋向性和 AFP 启动子的复制腺病毒条件性复制限制用于治疗肝细胞癌
- 批准号:
10436626 - 财政年份:2021
- 资助金额:
$ 29.53万 - 项目类别:
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
- 批准号:
10557162 - 财政年份:2021
- 资助金额:
$ 29.53万 - 项目类别:
Molecular therapy of replication-competent adenoviruses targeting characteristic gene mutations found in mesothelioma
针对间皮瘤中发现的特征基因突变的具有复制能力的腺病毒的分子疗法
- 批准号:
21K08199 - 财政年份:2021
- 资助金额:
$ 29.53万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
- 批准号:
10330464 - 财政年份:2021
- 资助金额:
$ 29.53万 - 项目类别:
Structural characterization of nucleoprotein cores of human adenoviruses
人腺病毒核蛋白核心的结构表征
- 批准号:
9807741 - 财政年份:2019
- 资助金额:
$ 29.53万 - 项目类别:
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
- 批准号:
41625-2013 - 财政年份:2018
- 资助金额:
$ 29.53万 - 项目类别:
Discovery Grants Program - Individual
The therapeutic strategies with augmented replications of oncolytic adenoviruses for malignant mesothelioma
溶瘤腺病毒增强复制治疗恶性间皮瘤的治疗策略
- 批准号:
18K15937 - 财政年份:2018
- 资助金额:
$ 29.53万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
- 批准号:
41625-2013 - 财政年份:2017
- 资助金额:
$ 29.53万 - 项目类别:
Discovery Grants Program - Individual
Exploring the effects of nutrient deprivation on T cells and oncolytic adenoviruses, in order to create immune activators for tumour therapy
探索营养剥夺对 T 细胞和溶瘤腺病毒的影响,以创造用于肿瘤治疗的免疫激活剂
- 批准号:
1813152 - 财政年份:2016
- 资助金额:
$ 29.53万 - 项目类别:
Studentship
Research on detection of novel adenoviruses by genetic methods
新型腺病毒的基因检测研究
- 批准号:
16K09118 - 财政年份:2016
- 资助金额:
$ 29.53万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




